Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

ClinicalTrials.gov ID: NCT05107128

Public ClinicalTrials.gov record NCT05107128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.

Study identification

NCT ID
NCT05107128
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
25 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 25, 2022
Primary completion
Sep 3, 2024
Completion
Oct 2, 2024
Last update posted
Sep 14, 2025

2022 – 2024

United States locations

U.S. sites
34
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Sage Investigational Site Little Rock Arkansas 72205
Sage Investigational Site La Jolla California 92037
Sage Investigational Site Los Angeles California 90095
Sage Investigational Site Sacramento California 95817
Sage Investigational Site Englewood Colorado 80113
Sage Investigational Site Washington D.C. District of Columbia 20007
Sage Investigational Site Boca Raton Florida 33431
Sage Investigational Site Boca Raton Florida 33486
Sage Investigational Site Tampa Florida 33612
Sage Investigational Site Honolulu Hawaii 96817
Sage Investigational Site Chicago Illinois 60611
Sage Investigational Site Chicago Illinois 60612
Sage Investigational Site Indianapolis Indiana 46202
Sage Investigational Site Iowa City Iowa 52242
Sage Investigational Site Kansas City Kansas 66160
Sage Investigational Site Baltimore Maryland 21287
Sage Investigational Site Boston Massachusetts 02129
Sage Investigational Site Boston Massachusetts 02215
Sage Investigational Site Farmington Hills Michigan 48334
Sage Investigational Site Buffalo New York 14221
Sage Investigational Site New York New York 10032
Sage Investigational Site Chapel Hill North Carolina 27599
Sage Investigational Site Durham North Carolina 27705
Sage Investigational Site Cincinnati Ohio 45219
Sage Investigational Site Toledo Ohio 43614
Sage Investigational Site Philadelphia Pennsylvania 19107
Sage Investigational Site Charleston South Carolina 29425
Sage Investigational Site Memphis Tennessee 38157
Sage Investigational Site Nashville Tennessee 37212
Sage Investigational Site Houston Texas 77030
Sage Investigational Site Richmond Virginia 23298
Sage Investigational Site Kirkland Washington 98034
Sage Investigational Site Spokane Washington 99202
Sage Investigational Site Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05107128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05107128 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →